CGRP receptor antagonists
US9688660B2 · kind B2 · utility
5Cited by
20References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2016 |
| Grant date | Jun 27, 2017 |
| Priority date | — |
| Expiry date | Oct 28, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosures herein relate to novel compounds of formulawherein Ar1 and R1 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.